$ELVR

Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.

Original reporting
Published Aug 24, 2026, 2:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 2:56 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium — source image
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

The deal provides Elevra with a stable revenue stream, price floor protection, and reduced logistics costs, likely supporting its valuation.

02

Market read

First‑report of a material supply contract that could positively affect Elevra's share price and the broader North American lithium sector.

03

What to watch

Financing risk for Mangrove's conversion plant and potential delays in FID could affect contract execution.

Relevance 7/10Novelty 7/10Timing: announced today

Background

Elevra Lithium (NASDAQ:ELVR) secured a seven‑year supply agreement with Mangrove Lithium for spodumene concentrate from its North American Lithium project in Quebec.

Company-level read

Ticker impact

$ELVRBullishHigh confidence
Context

Elevra Lithium announced a binding Spodumene Concentrate Supply Agreement with Mangrove Lithium, securing long‑term off‑take and price floor.

Expected impact

Potential upside as market price for spodumene may rise; floor price above cost supports margins.

Evidence & confidence

New multi‑year supply deal with volume up to 144,000 dmt and no price ceiling gives Elevra exposure to price upside and reduces freight costs.

Market effects

Strengthens North American lithium supply chain, may benefit other battery‑material producers.

Boosts Canadian lithium sector confidence with Canada Growth Fund backing.

Adds to global lithium supply security, could influence lithium pricing trends.

Counterpoint

If market spodumene prices fall, the floor may limit upside and the contract could become a cost drag.

Key entities

  • Elevra Lithium Ltd

    North American lithium producer listed on NASDAQ (ELVR).

  • Mangrove Lithium

    Private lithium refining technology firm developing a conversion facility in Eastern Canada.

Related articles

$ELVRMed

Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) finalized a binding supply agreement with Mangrove Lithium for long-term spodumene concentrate supply from its North American Lithium facility in Québec. The deal follows a previous MoU and includes a price floor above production costs and no price ceiling. Elevra aims to avoid seaborne freight costs by supplying a local customer.

$ELVRMed

Elevra Lithium Limited: Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) signed a binding 7-year spodumene supply deal with Mangrove Lithium, extendable for another 7 years. The agreement covers 122,000 tonnes annually, with a floor price above Elevra's production costs and no ceiling. Both companies are backed by the Canada Growth Fund, aiming to strengthen Canada's lithium supply chain. Mangrove must reach a final investment decision by 2028.

$ELVRMed

Elevra Lithium Q4 Earnings Call Highlights

Elevra Lithium (NASDAQ:ELVR) reported June-quarter revenue of $31 billion and average realized price of $921 per tonne, with unit operating costs of $907 per tonne. Full-year unit operating costs were $853 per tonne, below revised guidance of $860 to $880. The company raised $207 million net from equity and $145 million CAD via convertible notes, funded NAL expansion, and expects higher shipping volumes.

$ELVRMed

Elevra Lithium Quarterly Activities Report

Elevra Lithium Limited (ASX: ELV, NASDAQ: ELVR) reported June 2026 quarter results for North American Lithium. Ore mined was 372,938 wmt, process plant utilisation 92%, lithium recoveries 71%, and spodumene concentrate 54,479 dmt. Spodumene sales were 33,977 dmt at US$921/dmt for US$31m revenue. Elevra also announced a US$196m placement plus US$102m convertible notes to fund the NAL expansion, and said cash was US$255m at quarter end.

$ELVRMed

Elevra Lithium Limited (ASX:ELV) EGM - Chair Address and EGM Slides

Elevra Lithium Limited (ASX:ELV, NASDAQ:ELVR, OTC:SYAXF) said at its 2026 EGM it plans a three-stage North American Lithium brownfield expansion to raise annual spodumene concentrate capacity to 338ktpa by 2029. It targets 4,500 tpd milling throughput in Stage 1, 6,500 tpd by 2028 in Stage 2, and lower unit costs in Stage 3. The A$508M funding package includes A$275M equity, A$146M convertible notes from Canada Growth Fund, and about A$87M net proceeds from divesting Ghana’s Ewoyaa. The updated